Drugs Made In America Acquisition Corp. DMAA
$10.80
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2,437.50% | 1,555.56% | 335.71% | -66.67% | -95.58% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | -- | 69.44% | -- | -18.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 39.24% | -79.01% | 144.00% | 1,242.86% | -36.36% |
|
|
|||||
| Total Current Assets | 39.24% | -79.01% | 144.00% | 1,242.86% | -36.36% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -37.56% | 3.99% | 43,855.06% | 55,938.73% | 208,002.65% |
| Total Assets | -37.54% | 3.96% | 43,458.24% | 55,669.16% | 122,979.91% |
|
|
|||||
| Total Accounts Payable | 72.47% | 79.77% | 187.45% | -- | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 64.20% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1,419.61% | 0.00% | 174.51% | 387.34% | 17,011.11% |
| Total Other Current Liabilities | 1,419.61% | 0.00% | 174.51% | 387.34% | 17,011.11% |
| Total Current Liabilities | 876.97% | 41.68% | -52.72% | -22.74% | 42.84% |
|
|
|||||
| Total Current Liabilities | 876.97% | 41.68% | -52.72% | -22.74% | 42.84% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 64.20% | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -37.47% | 3.87% | -- | -- | -- |
| Total Liabilities | -36.33% | 3.93% | 30,964.82% | 41,348.53% | 114,761.33% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | -96.86% | -96.86% | -96.86% |
| Retained Earnings | -14.72% | -16.65% | -2,496.53% | -3,261.98% | -11,661.20% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.56% | -2.80% | -2,867.32% | -4,344.15% | -35,838.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.56% | -2.80% | -2,867.32% | -4,344.15% | -35,838.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.56% | -2.80% | -2,867.32% | -4,344.15% | -35,838.19% |
|
|
|||||